By Andrew Karpan (October 15, 2024, 5:32 PM EDT) — Swiss drugmaker Novartis said Tuesday that it plans to appeal a ruling from over the weekend that scuttled its suit over the U.S. Food and Drug Administration’s approval of a generic version of Entresto, the drugmaker’s blockbuster heart failure medication….

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

• Daily newsletters
• Expert analysis
• Mobile app
• Advanced search
• Judge information
• Real-time alerts
• 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.